Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21443089rdf:typepubmed:Citationlld:pubmed
pubmed-article:21443089lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21443089lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:21443089lifeskim:mentionsumls-concept:C0155773lld:lifeskim
pubmed-article:21443089lifeskim:mentionsumls-concept:C0796679lld:lifeskim
pubmed-article:21443089lifeskim:mentionsumls-concept:C1519810lld:lifeskim
pubmed-article:21443089pubmed:issue104lld:pubmed
pubmed-article:21443089pubmed:dateCreated2011-3-29lld:pubmed
pubmed-article:21443089pubmed:abstractTextChemoembolization in the presence of portal vein thrombosis (PVT) is thought to be hazardous and such patients are regarded as prognostically poor.lld:pubmed
pubmed-article:21443089pubmed:languageenglld:pubmed
pubmed-article:21443089pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21443089pubmed:citationSubsetIMlld:pubmed
pubmed-article:21443089pubmed:statusMEDLINElld:pubmed
pubmed-article:21443089pubmed:issn0172-6390lld:pubmed
pubmed-article:21443089pubmed:authorpubmed-author:FederleMichae...lld:pubmed
pubmed-article:21443089pubmed:authorpubmed-author:CarrBrian IBIlld:pubmed
pubmed-article:21443089pubmed:authorpubmed-author:IrishWilliamWlld:pubmed
pubmed-article:21443089pubmed:issnTypePrintlld:pubmed
pubmed-article:21443089pubmed:volume57lld:pubmed
pubmed-article:21443089pubmed:ownerNLMlld:pubmed
pubmed-article:21443089pubmed:authorsCompleteYlld:pubmed
pubmed-article:21443089pubmed:pagination1375-81lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:meshHeadingpubmed-meshheading:21443089...lld:pubmed
pubmed-article:21443089pubmed:articleTitleChemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis.lld:pubmed
pubmed-article:21443089pubmed:affiliationUniversity of Pittsburgh Medical Center, Dept of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. brianicarr@hotmail.comlld:pubmed
pubmed-article:21443089pubmed:publicationTypeJournal Articlelld:pubmed